Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. AN2 Therapeutics Inc shares valued at $3,965 were sold by Day Lucy on Jan 03 ’25. At $1.34 per share, Day Lucy sold 2,957 shares. The insider’s holdings dropped to 32,670 shares worth approximately $42471.0 following the completion of this transaction.
Also, Chanda Sanjay sold 2,957 shares, netting a total of over 3,965 in proceeds. Following the sale of shares at $1.34 each, the insider now holds 29,824 shares.
Before that, Prior Stephen David had sold 2,029 shares from its account. In a trade valued at $2,721, the Chief Strategy Officer traded AN2 Therapeutics Inc shares for $1.34 each. Upon closing the transaction, the insider’s holdings decreased to 2,029 shares, worth approximately $43306.9.
As published in a research note from Leerink Partners on August 09, 2024, AN2 Therapeutics Inc [ANTX] has been rated down from an Outperform to a Market perform and the price target has been revised to $1 from $5. Analysts at Evercore ISI downgraded the stock from ‘”an In-line”‘ to ‘”an Underperform”‘ outlook in a report released in early August. As of July 03, 2024, Leerink Partners has increased its “Market perform” rating to a “an Outperform” for ANTX. Earlier on April 02, 2024, JMP Securities upgraded its rating. Their new recommendation was “a Mkt outperform” for ANTX stock which previously was a “a Mkt perform”.
Analyzing ANTX Stock Performance
During the last five days, there has been a drop of approximately -5.80%. Over the course of the year, AN2 Therapeutics Inc shares have dropped approximately -5.80%. Shares of the company reached a 52-week high of $1.4400 on 01/06/25 and a 52-week low of $1.2909 on 01/08/25. A 50-day SMA is recorded $1.2890, while a 200-day SMA reached $1.7915. Nevertheless, trading volume fell to 81992.0 shares from 63600.0 shares the previous day.
Support And Resistance Levels for AN2 Therapeutics Inc (ANTX)
According to the 24-hour chart, there is a support level at 1.2706, which, if violated, would cause prices to drop to 1.2412. In the upper region, resistance lies at 1.3497. The next price resistance is at 1.3994. RSI (Relative Strength Index) is 44.78 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0174, which suggests the price will decrease in the coming days. Percent R is at 68.18%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
